| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.560 | 28.661 | 26.645 | 34.054 | 36.830 | 29.527 | 29.504 | 49.090 | 55.198 | 51.696 |
| Total Income - EUR | 26.773 | 29.566 | 27.236 | 35.021 | 47.261 | 30.917 | 42.458 | 56.011 | 55.198 | 51.696 |
| Total Expenses - EUR | 29.604 | 35.927 | 30.782 | 41.839 | 50.238 | 42.414 | 38.399 | 55.438 | 49.683 | 53.229 |
| Gross Profit/Loss - EUR | -2.831 | -6.360 | -3.545 | -6.819 | -2.977 | -11.498 | 4.059 | 573 | 5.515 | -1.533 |
| Net Profit/Loss - EUR | -3.598 | -6.947 | -4.362 | -7.313 | -3.341 | -11.769 | 3.917 | 82 | 4.963 | -2.050 |
| Employees | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Nervomax Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.779 | 4.214 |
| Current Assets | 10.815 | 13.894 | 16.352 | 15.787 | 26.353 | 24.179 | 20.137 | 741 | 4.671 | 4.471 |
| Inventories | 9.501 | 12.764 | 15.990 | 14.740 | 14.618 | 12.380 | 20.103 | 591 | 1.479 | 60 |
| Receivables | 208 | 118 | 0 | 0 | 459 | 0 | 0 | 0 | 8 | 8 |
| Cash | 1.105 | 1.012 | 362 | 1.047 | 11.276 | 11.799 | 35 | 150 | 3.184 | 4.403 |
| Shareholders Funds | -16.375 | -23.155 | -27.126 | -33.941 | -36.625 | -47.700 | -32.372 | -32.390 | -27.329 | -29.226 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.190 | 37.050 | 43.478 | 49.728 | 62.978 | 71.879 | 52.509 | 33.132 | 37.779 | 37.912 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4724 - 4724" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Nervomax Impex Srl